QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.19%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-3.97%)
GE   106.07 (+-0.01%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.19%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-3.97%)
GE   106.07 (+-0.01%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.19%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-3.97%)
GE   106.07 (+-0.01%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.19%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-3.97%)
GE   106.07 (+-0.01%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
NASDAQ:AVTX

Avalo Therapeutics (AVTX) Insider Trading & Ownership

$4.15
+0.26 (+6.68%)
(As of 05:11 PM ET)
Compare
Today's Range
$3.74
▼
$4.26
50-Day Range
$1.75
▼
$3.89
52-Week Range
$1.41
▼
$7.41
Volume
41,972 shs
Average Volume
48,460 shs
Market Capitalization
$54.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.50
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Avalo Therapeutics (NASDAQ:AVTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
45.40%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$318,884.59
Number Of
Insiders Selling
(Last 12 Months)
0

AVTX Insider Buying and Selling by Quarter

Get AVTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Avalo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Avalo Therapeutics Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/30/2023Caissa Capital Management Ltd.Major ShareholderBuy671$2.87$1,925.771,385,371  
5/25/2023Caissa Capital Management Ltd.Major ShareholderBuy2,000$2.77$5,540.001,384,700  
5/22/2023Caissa Capital Management Ltd.Major ShareholderBuy7,000$3.34$23,380.001,373,700  
5/18/2023Caissa Capital Management Ltd.Major ShareholderBuy13,121$3.29$43,168.091,360,200  
5/15/2023Caissa Capital Management Ltd.Major ShareholderBuy1,715$2.55$4,373.251,346,700  
5/12/2023Caissa Capital Management Ltd.Major ShareholderBuy2,285$2.45$5,598.251,344,985  
5/8/2023Caissa Capital Management Ltd.Major ShareholderBuy5,000$2.62$13,100.001,342,700  
5/4/2023Caissa Capital Management Ltd.Major ShareholderBuy15,000$2.79$41,850.001,332,700  
4/26/2023Caissa Capital Management Ltd.Major ShareholderBuy425$2.97$1,262.251,316,196  
4/24/2023Caissa Capital Management Ltd.Major ShareholderBuy12,500$3.06$38,250.001,310,200  
4/20/2023Caissa Capital Management Ltd.Major ShareholderBuy5,000$3.08$15,400.001,297,700  
4/17/2023Caissa Capital Management Ltd.Major ShareholderBuy15,000$2.96$44,400.001,282,700  
4/10/2023Caissa Capital Management Ltd.Major ShareholderBuy31,329$2.28$71,430.121,242,700  
12/9/2022Garry Arthur NeilCEOBuy2,083$4.42$9,206.869,220  
(Data available from 1/1/2013 forward)












AVTX Insider Trading Activity - Frequently Asked Questions

Who is on Avalo Therapeutics's Insider Roster?

The list of insiders at Avalo Therapeutics includes Armistice Capital, Llc, Caissa Capital Management Ltd., Christopher Ryan Sullivan, Garry Arthur Neil, H Jeffrey Wilkins, and Schond L Greenway. Learn more on insiders at AVTX.

What percentage of Avalo Therapeutics stock is owned by insiders?

45.40% of Avalo Therapeutics stock is owned by insiders. Learn more on AVTX's insider holdings.

Which Avalo Therapeutics insiders have been buying company stock?

The following insiders have purchased AVTX shares in the last 24 months: Armistice Capital, Llc ($1,558,598.03), Caissa Capital Management Ltd. ($309,677.73), Christopher Ryan Sullivan ($1,499.35), Garry Arthur Neil ($9,206.86), H Jeffrey Wilkins ($10,002.47), and Schond L Greenway ($3,502.67).

How much insider buying is happening at Avalo Therapeutics?

Insiders have purchased a total of 1,946,283 AVTX shares in the last 24 months for a total of $1,892,487.11 bought.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:AVTX) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -